Thai Ministry, U.S. Industries Agree To Compulsory License Compromise
This article was originally published in PharmAsia News
Thai officials and U.S. industries have agreed in principle to make some drugs more accessible to Thais short of imposing compulsory licenses. Thailand's Commerce Ministry met with groups representing U.S. drug makers and biotech companies. The three parties agreed to cooperate on Thai research and development to give the nation the capability of producing its own less-expensive quality drugs. In exchange, the government would refrain from imposing compulsory licensing except as a last resort. (Click here for more
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.